About Living Pharma
Living Pharma is a company based in Baltimore (United States) founded in 2015 was acquired by Lentigen in July 2017. Living Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, Insitro, BridgeBio, Celgene and ATAI, among others.
- Headquarter Baltimore, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Living Pharma
Detailed funding history for Living Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Living Pharma
Living Pharma has secured backing from 1 investor. Prominent investors backing the company include Lentigen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Lentiviral vectors are developed for pre-clinical and clinical applications.
|
Locked | Locked | Locked |
Investor details for Living Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Living Pharma
Investment portfolio details for Living Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Living Pharma
Detailed financials for Living Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Living Pharma Comparisons
Peer comparison for Living Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Living Pharma
Living Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Insitro, BridgeBio, Celgene and ATAI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
Detailed competitors of Living Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Living Pharma
Complete news archive for Living Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Living Pharma
Living Pharma was founded in 2015.
Living Pharma is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Living Pharma develops personalised CAR T Cell therapies to treat cancer. They are focused on developing therapeutic immuno-oncology products optimised for each individual patient. The companys Universal Anti-Tag Chimeric Antigen Receptor (AT-CAR) engineered T cell can be tailored to each individual patients cancer and disease phenotype. AT-CAR T cells recognize a tagged tumor-targeting molecule (which could be an anti-tumor MAb, Soluble T Cell Receptor, or a Cytokine). The companys universal AT-CAR T cells target and eradicate multiple cancer types through the use of a panel of ATCs, each ATC recognizing a unique tumor-associated antigen.
Living Pharma's top competitors include Jazz Pharmaceuticals, Spark Therapeutics and BridgeBio.
Living Pharma has 1 investor. Key investors include Lentigen.